HRA000176
Title:
The influence of immune heterogeneity on the effectiveness of immune checkpoint inhibitors in multifocal hepatocellular carcinomas
Release date:
2020-09-30
Description:
Immunotherapy is emerging as a promising strategy in hepatocellular carcinoma (HCC), but its low response rate and mixed responses among different nodules remained to be a major challenge. In this study, we deciphered genomic and immune characteristics among tumors with different sizes in multifocal HCC patients through whole genome sequencing and RNA sequencing. We found the small and large nodules within the same patient presented with similar genomic characteristics, indicating that the small and large nodules were intrahepatic metastasis. Further analysis revealed that the small tumors had higher immune cell infiltration and upregulation of immune pathways as compared to the large tumor of the same multifocal HCC case, which may partially explain the different responses of small and large tumors to anti-PD-1 treatment.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
hepatocellular carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
multifocal HCC
Contact person:
Peng Sui
Email:
pengsui@vip.163.com
Description:
multifocal hepatocellular carcinomas
Individuals & samples
Submitter:   Peng Sui / pengsui@vip.163.com
Organization:   The First Affiliated Hospital, Sun Yat-sen University
Submission date:   2020-05-23
Requests:   1